Factsheet – How the European Commission works on Rare Diseases and the European Reference Networks (ERNs)

1:1
Overview of the European Commission’s coordinated approach to rare diseases, including policy, research, and the role of European Reference Networks.

This factsheet outlines how the European Commission supports action on rare diseases through policy frameworks, research funding, and collaboration across Member States. It explains the role of European Reference Networks (ERNs) as cross-border networks connecting specialised centres to address rare and complex conditions, and highlights initiatives related to orphan medicines, medical devices, and data sharing, including the European Health Data Space.

Year of publication

2026

Source

European Commission – Directorate-General for Health and Food Safety

Author

Directorate-General for Health and Food Safety (European Commission)

You might also be interested in

Call text draft setting out rules, eligibility and staged application process for the ERDERA Clinical Trial Call 2026.
June 7 - June 10
The Open Academy x ERDERA accompanies patient advocates by offering rare-disease specific comprehensive training programmes that empower advocates with the knowledge, skills and confidence they need to engage with different stakeholders as equal partners.
ERDERA’s ethics and regulatory experts are launching a dedicated webinar series to help the rare disease research community navigate two fast-moving areas of biomedical research: Advanced Therapy Medicinal Products (ATMPs) and Artificial Intelligence.
July 24 @ 3:00 pm - 4:00 pm
This webinar will present a theoretical framework for situating ethics across research activities. The framework will then be brought to life through a relevant case study discussion, giving participants a concrete reference point for the episodes ahead.